BrainCool
1.642 SEK +2.37%4 investors are following this company
BrainCool develops products used for medical cooling of the human brain. The technology acts as cooling pads that are applied to different part of the patient's body, where the system controls the body temperature and other movements. The products are used in the treatment of various severe conditions such as stroke, cardiac arrest, concussion, and migraine. BrainCool was founded in 2010 and is based in Lund.
Revenue
23.23M
EBIT %
-233.15 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
BRAIN
Daily low / high price
1.55 / 1.69
SEK
Market cap
416.07M SEK
Turnover
1.53M SEK
Volume
936K
Latest videos
Financial calendar
General meeting
26.06.2024
Interim report
15.08.2024
Interim report
01.11.2024
Annual report
03.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 10.8 % | 10.8 % |
Landia AB | 7.5 % | 7.5 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
BrainCool AB (publ) carries out a rights issue of SEK 85.8 million
Correction: BrainCool AB (publ) - Financial Report for Q1 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools